303 related articles for article (PubMed ID: 33160340)
21. Post-chemotherapy retroperitoneal teratoma in nonseminomatous germ cell tumors: Do predictive factors exist? Results from a national multicenter study.
Dusaud M; Malavaud B; Bayoud Y; Sebe P; Hoepffner JL; Salomon L; Houlgatte A; Pignot G; Rigaud J; Fléchon A; Pfister C; Rouprêt M; Soulié M; Méjean A; Durand X
J Surg Oncol; 2016 Dec; 114(8):992-996. PubMed ID: 27859263
[TBL] [Abstract][Full Text] [Related]
22. Risk of Bleomycin-Related Pulmonary Toxicities and Operative Morbidity After Postchemotherapy Retroperitoneal Lymph Node Dissection in Patients With Good-Risk Germ Cell Tumors.
Calaway AC; Foster RS; Adra N; Masterson TA; Albany C; Hanna NH; Einhorn LH; Cary C
J Clin Oncol; 2018 Oct; 36(29):2950-2954. PubMed ID: 30156983
[TBL] [Abstract][Full Text] [Related]
23. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
[TBL] [Abstract][Full Text] [Related]
24. Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour.
Fléchon A; Tavernier E; Boyle H; Meeus P; Rivoire M; Droz JP
BJU Int; 2010 Sep; 106(6):779-85. PubMed ID: 20089110
[TBL] [Abstract][Full Text] [Related]
25. Rates of teratoma and viable cancer at post-chemotherapy retroperitoneal lymph node dissection after induction chemotherapy for good risk nonseminomatous germ cell tumors.
Kundu SD; Feldman DR; Carver BS; Gupta A; Bosl GJ; Motzer RJ; Bajorin DF; Sheinfeld J
J Urol; 2015 Feb; 193(2):513-8. PubMed ID: 25150639
[TBL] [Abstract][Full Text] [Related]
26. [Temporary transsection of the inferior vena cava for complete removal of a retroperitoneal metastatic testicular tumor].
Kumada K; Okada Y; Okada K; Morikawa S; Yoshida O
Chirurg; 1988 Oct; 59(10):676-8. PubMed ID: 2848663
[No Abstract] [Full Text] [Related]
27. Long-term outcome of patients with clinical stage I high-risk nonseminomatous germ-cell tumors 15 years after one adjuvant cycle of bleomycin, etoposide, and cisplatin chemotherapy.
Vidal AD; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
Ann Oncol; 2015 Feb; 26(2):374-7. PubMed ID: 25392157
[TBL] [Abstract][Full Text] [Related]
28. Vena caval reconstruction during postchemotherapy retroperitoneal lymph node dissection for metastatic germ cell tumor.
Ehrlich Y; Kedar D; Zelikovski A; Konichezky M; Baniel J
Urology; 2009 Feb; 73(2):442.e17-9. PubMed ID: 18436290
[TBL] [Abstract][Full Text] [Related]
29. Delayed orchiectomy after chemotherapy in patients with advanced testicular cancer.
Ondrus D; Hornák M; Breza J; Mat'oska J; Schnorrer M; Belan V; Kausitz J
Int Urol Nephrol; 2001; 32(4):665-7. PubMed ID: 11989561
[TBL] [Abstract][Full Text] [Related]
30. Post-chemotherapy retroperitoneal lymph node dissection in the management of metastatic testis cancer: the 16-year experience in an Irish setting.
Considine S; Heaney R; Conroy R; Thornhill JA
Ir J Med Sci; 2016 Nov; 185(4):901-907. PubMed ID: 26692387
[TBL] [Abstract][Full Text] [Related]
31. Successful 2-year-long remission following repeated salvage surgery in a patient with chemotherapy-resistant metastatic nonseminomatous germ cell tumor.
Takeshita H; Yonese J; Fujii Y; Kawakami S; Komai Y; Ohkubo Y; Yamamoto S; Ishikawa Y; Seto Y; Ohyama S; Fukui I
Int J Clin Oncol; 2007 Dec; 12(6):485-7. PubMed ID: 18071871
[TBL] [Abstract][Full Text] [Related]
32. Management of patients with clinical stage I or II nonseminomatous germ cell tumors of the testis. Evolving therapeutic options.
Richie JP; Socinsky MA; Fung CY; Brodsky GL; Kalish LA; Garnick MB
Arch Surg; 1987 Dec; 122(12):1443-5. PubMed ID: 2446590
[TBL] [Abstract][Full Text] [Related]
33. Retroperitoneal lymph node dissection after chemotherapy.
Winter C; Raman JD; Sheinfeld J; Albers P
BJU Int; 2009 Nov; 104(9 Pt B):1404-12. PubMed ID: 19840021
[TBL] [Abstract][Full Text] [Related]
34. Non-seminomatous Germ Cell Tumor Causing an Inferior Vena Cava Thrombus in a Sixteen-Year-Old Male.
Fratino KM; Burton BR; Shukla M; Klaassen ZW; Morganstern BA
Am Surg; 2021 Apr; 87(4):655-657. PubMed ID: 33153271
[No Abstract] [Full Text] [Related]
35. [Testicular cancer with inferior vena caval embolus causing pulmonary embolism following chemotherapy: a case report].
Akamatsu S; Tsukazaki H; Inoue K; Nishio Y
Hinyokika Kiyo; 2004 May; 50(5):327-9. PubMed ID: 15237486
[TBL] [Abstract][Full Text] [Related]
36. [Retroperitoneal surgery in the treatment of germ-cell tumors of the testis: retroperitoneal lymph node dissection (RPLND)].
Nicolai N; Necchi A; Piva L; Stagni S; Catanzaro MA; Biasoni D; Milani A; Torelli T; Salvioni R
Urologia; 2010; 77(2):84-7. PubMed ID: 20890864
[TBL] [Abstract][Full Text] [Related]
37. Management of post-chemotherapy extra-retroperitoneal residual masses.
Carver BS; Sheinfeld J
World J Urol; 2009 Aug; 27(4):489-92. PubMed ID: 19373472
[TBL] [Abstract][Full Text] [Related]
38. Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor?
Beck SD; Foster RS; Bihrle R; Donohue JP; Einhorn LH
Cancer; 2007 Sep; 110(6):1235-40. PubMed ID: 17665498
[TBL] [Abstract][Full Text] [Related]
39. Radical retroperitoneal node dissection after chemotherapy for testicular tumours.
Williams SN; Jenkins BJ; Baithun SI; Oliver RT; Blandy JP
Br J Urol; 1989 Jun; 63(6):641-3. PubMed ID: 2546643
[TBL] [Abstract][Full Text] [Related]
40. Quality-of-Life Analysis of the German Prospective Multicentre Trial of Single-cycle Adjuvant BEP Versus Retroperitoneal Lymph Node Dissection in Clinical Stage I Nonseminomatous Germ Cell Tumours.
Flechtner HH; Fischer F; Albers P; Hartmann M; Siener R;
Eur Urol; 2016 Mar; 69(3):518-25. PubMed ID: 26620368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
